Immunology
173.9K views | +20 today
Follow
Immunology
Teaching and Learning Immunology. Information you never would have searched for!
Your new post is loading...
Your new post is loading...
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: What we learn from intrathymic migration - Cowan - 2015 - European Journal of Immunology - Wi...

Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: What we learn from intrathymic migration - Cowan - 2015 - European Journal of Immunology - Wi... | Immunology | Scoop.it
Abstract

The organization of the thymus into distinct cortical and medullary regions enables it to control the step-wise migration and development of immature T-cell precursors. Such a process provides access to specialized cortical and medullary thymic epithelial cells at defined stages of maturation, ensuring the generation of self-tolerant and MHC-restricted conventional CD4+ and CD8+ αβ T cells. The migratory cues and stromal cell requirements that regulate the development of conventional αβ T cells have been well studied. However, the thymus also fosters the generation of several immunoregulatory T-cell populations that form key components of both innate and adaptive immune responses. These include Foxp3+ natural regulatory T cells, invariant γδ T cells, and CD1d-restricted invariant natural killer T cells (iNKT cells). While less is known about the intrathymic requirements of these nonconventional T cells, recent studies have highlighted the importance of the thymus medulla in their development. Here, we review recent findings on the mechanisms controlling the intrathymic migration of distinct T-cell subsets, and relate this to knowledge of the microenvironmental requirements of these cells.


Via Krishan Maggon
Krishan Maggon 's curator insight, February 18, 2015 2:14 AM

Mini-Review

Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: What we learn from intrathymic migrationAuthorsJennifer E. Cowan, William E. Jenkinson, Graham Anderson First published: 13 February 2015Full publication historyDOI: 10.1002/eji.201445108
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

ImmunID's Immune Testing Platform

ImmunID's Immune Testing Platform | Immunology | Scoop.it

ImmunID has developed immune tests to measure T cell diversity and B cell diversity, in a quantitative and exhaustive way. These tests use a patented multi-N-plex® quantitative PCR technology to detect and characterize V-J rearrangements of the T and B cell receptor at the genomic DNA level. The assay allows the simultaneous detection of several V–J rearrangements in the same reaction and covers 100% of the possible combinatorial rearrangements (for more information on immunogenetics, please refer to the International ImMunoGeneTics Information System).

Immune profiling on a platform compatible with clinical routine requirements

ImmunID’s proprietary testing platform combines quantitative PCR, microfluidics and bioinformatics. ImmunID’s tests allow to translate the complexity of the immune repertoire into easily-visualized and interpretable data.

Immune testing is performed on ImmunID’s platform in 3 main steps:

Preanalytical samples preparation : genomic DNA extraction and Quality ControlsQuantitative multi-N-plex® Polymerase Chain Reaction and amplicons detection by microfluidicsData analysis by our proprietary Constel ID® software


Via Krishan Maggon
Gilbert C FAURE's insight:

ImmunID is the first company able to provide a standardized analysis of the immune statusthrough the evaluation of immune diversity with a test compatible with clinical research and, in the future, with medical routine.

ImmunID spun out of the laboratories of the CEA in 2005 in Grenoble, France. The CEA is a French government-funded technological research organization, in which the two co-founders, Nicolas Pasqual and Sébastien Weisbuch, were working as scientists. Both truly believed in the value and potential of the immune profiling technologies they had been developing, and decided to create ImmunID. Just a few months after the inception of the company, Nadia Plantier and Jean-Francois Mouret joined Nicolas and Sébastien, in order to further develop these game-changing technologies and to bring them to patients and physicians, through a simple, reliable and clinically meaningful immune status test.

unfortunately not yet applicable in immune monitoring assays in franch university hospitals

Krishan Maggon 's curator insight, December 12, 2014 8:29 AM
Immune repertoire characterization: in the context of a pathology, of a mouse model, or of a treatment, for exampleImmune monitoring: to evaluate the impact of a therapeutic candidate and characterize its competitive advantage in regards to efficiency and safetyPatient stratification: using immune profiles as a biomarker (prognosis biomarker, safety biomarker, biomarker of response, predictive biomarker) and possibly accelerate the development of drug candidates by identifying & selecting patients who are the most suitable for therapy
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection
Scoop.it!

The biology of innate lymphoid cells

The innate immune system is composed of a diverse array of evolutionarily ancient haematopoietic cell types, including dendritic cells, monocytes, macrophages and granulocytes. These cell populations collaborate with each other, with the adaptive immune system and with non-haematopoietic cells to promote immunity, inflammation and tissue repair. Innate lymphoid cells are the most recently identified constituents of the innate immune system and have been the focus of intense investigation over the past five years. We summarize the studies that formally identified innate lymphoid cells and highlight their emerging roles in controlling tissue homeostasis in the context of infection, chronic inflammation, metabolic disease and cancer.


Via Krishan Maggon
Gilbert C FAURE's insight:

Group 1, group 2 and group 3 innate lymphoid cells (ILCs) are defined by differential expression of cell-surface markers, transcription factors and patterns of expression of effector cytokines.

Krishan Maggon 's curator insight, January 15, 2015 2:36 AM
The biology of innate lymphoid cellsDavid Artis& Hergen SpitsAffiliationsCorresponding authorsNature 517, 293–301 (15 January 2015) doi:10.1038/nature14189Received 26 September 2014 Accepted 04 November 2014 Published online 14 January 2015Figure 4: Pro-inflammatory and tissue reparative functions of innate lymphoid cells.